(Q37120274)

18 August 2017

Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. (English)

1 reference

18 August 2017

1 reference

Veda N Giri

1

1 reference

18 August 2017

Brian Egleston

2

1 reference

18 August 2017

Karen Ruth

3

1 reference

18 August 2017

Robert G Uzzo

4

1 reference

18 August 2017

David Y T Chen

5

1 reference

18 August 2017

Mark Buyyounouski

6

1 reference

18 August 2017

Susan Raysor

7

1 reference

18 August 2017

Stanley Hooker

8

1 reference

18 August 2017

Jada Benn Torres

9

1 reference

18 August 2017

Teniel Ramike

10

1 reference

18 August 2017

Kathleen Mastalski

11

1 reference

18 August 2017

Taylor Y Kim

12

1 reference

18 August 2017

Rick Kittles

13

1 reference

18 August 2017

24 February 2009

1 reference

Cancer Prevention Research

18 August 2017

1 reference

18 August 2017

2

1 reference

18 August 2017

3

1 reference

18 August 2017

244-250

1 reference

Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

The influence of finasteride on the development of prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Detection of high-grade prostatic intraepithelial neoplasia with the five-region biopsy technique

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Prostate cancer early detection. Clinical practice guidelines in oncology

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Prostate cancer risk assessment program: a 10-year update of cancer detection

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Hereditary prostate cancer: epidemiologic and clinical features

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Use of prostate-specific antigen in black men: age-adjusted reference ranges for maximal cancer detection.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652509

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer

3 September 2018

1 reference

12 December 2020

Screening for prostate cancer in high risk populations

1 reference

12 December 2020

The European Randomized Study of Screening for Prostate Cancer (ERSPC)

1 reference

12 December 2020

Prostate cancer risk assessment program. A model for the early detection of prostate cancer

1 reference

12 December 2020

Prostate cancer diagnosed by the 5 region biopsy method is significant disease

1 reference

12 December 2020

10.1158/1940-6207.CAPR-08-0150

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19240249

1 reference